Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2025-12-24 @ 5:05 PM
NCT ID:
NCT02525250
Eligibility Criteria:
Inclusion Criteria:
* Patient aged 18 years and above,
* Patient with myeloid acute leukemia or with myelodysplasic syndrome, treated or should be treated with Revlimid,
* Signed consent to participate,
* Patient affiliated to a social security system or benefiting from such as a system.
Exclusion Criteria:
* Allogeneic patients beyond,
* Patient deprived of liberty or under supervision of a guardian,
* Impossibility to undergo medical examinations of the study for geographical, social or psychological reasons.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02525250
Study Brief:
Protocol Section:
NCT02525250